조직공학 및 재생 시장(2026-2030년)

The global tissue engineering and regeneration market is forecasted to grow by USD 34886.0 mn during 2025-2030, accelerating at a CAGR of 16.0% during the forecast period. The report on the global tissue engineering and regeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising burden of chronic diseases, advancements in biomaterial scaffold engineering, expansion of stem cell research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global tissue engineering and regeneration market is segmented as below:

By Material

• Synthetic
• Biologic
• Genetically modified

By Application

• Ortho musculoskeletal and spine
• Dermatology
• Neurology
• Others

By Technology

• Stem cell technology
• 3D bioprinting
• Nanotechnology
• Decellularization
• Gene editing

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift toward organoid technology as one of the prime reasons driving the global tissue engineering and regeneration market growth during the next few years. Also, rise of vascularized scaffold engineering and expansion of dental regeneration applications will lead to sizable demand in the market.

The report on the global tissue engineering and regeneration market covers the following areas:

• Global tissue engineering and regeneration market sizing
• Global tissue engineering and regeneration market forecast
• Global tissue engineering and regeneration market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global tissue engineering and regeneration market vendors that include 3D Systems Corp., Aspect Biosystems Ltd., AxoGen Inc, BICO Group AB, CUTISS AG, Evergen, Integra LifeSciences Corp., Inventia Life Science, Japan Tissue Engineering Co., Matricel GmbH, MiMedx Group Inc., Organogenesis Holdings Inc., Orthocell Ltd, Poietis, regenHU Ltd., REPROCELL Inc., Secant Group, Synthasome Inc., Tissue Regenix Group Plc. Also, the global tissue engineering and regeneration market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Material
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Tissue Engineering And Regeneration Market 2020 - 2024
  • Historic Market Size - Data Table on Global Tissue Engineering And Regeneration Market 2020 - 2024 ($ million)
• 5.2 Material segment analysis 2020 - 2024
  • Historic Market Size - Material Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Tissue Engineering and Regeneration Market
• 6.2 Impact of geopolitical conflicts on Global Tissue Engineering and Regeneration Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Material

• 8.1 Market segments
• 8.2 Comparison by Material
• 8.3 Synthetic - Market size and forecast 2025-2030
• 8.4 Biologic - Market size and forecast 2025-2030
• 8.5 Genetically modified - Market size and forecast 2025-2030
• 8.6 Market opportunity by Material
  • Market opportunity by Material ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Ortho musculoskeletal and spine - Market size and forecast 2025-2030
• 9.4 Dermatology - Market size and forecast 2025-2030
• 9.5 Neurology - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 Stem cell technology - Market size and forecast 2025-2030
• 10.4 3D bioprinting - Market size and forecast 2025-2030
• 10.5 Nanotechnology - Market size and forecast 2025-2030
• 10.6 Decellularization - Market size and forecast 2025-2030
• 10.7 Gene editing - Market size and forecast 2025-2030
• 10.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising burden of chronic diseases
  • Advancements in biomaterial scaffold engineering
  • Expansion of stem cell research
• 13.2 Market challenges
  • High manufacturing and production complexity
  • Stringent regulatory approval pathways
  • Prohibitive treatment costs and reimbursement
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward organoid technology
  • Rise of vascularized scaffold engineering
  • Expansion of dental regeneration applications

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 3D Systems Corp.
  • 3D Systems Corp. - Overview
  • 3D Systems Corp. - Business segments
  • 3D Systems Corp. - Key offerings
  • 3D Systems Corp. - Segment focus
  • SWOT
• 15.5 Aspect Biosystems Ltd.
  • Aspect Biosystems Ltd. - Overview
  • Aspect Biosystems Ltd. - Product / Service
  • Aspect Biosystems Ltd. - Key offerings
  • SWOT
• 15.6 AxoGen Inc
  • AxoGen Inc - Overview
  • AxoGen Inc - Product / Service
  • AxoGen Inc - Key offerings
  • SWOT
• 15.7 BICO Group AB
  • BICO Group AB - Overview
  • BICO Group AB - Business segments
  • BICO Group AB - Key offerings
  • BICO Group AB - Segment focus
  • SWOT
• 15.8 CUTISS AG
  • CUTISS AG - Overview
  • CUTISS AG - Product / Service
  • CUTISS AG - Key offerings
  • SWOT
• 15.9 Evergen
  • Evergen - Overview
  • Evergen - Product / Service
  • Evergen - Key offerings
  • SWOT
• 15.10 Integra LifeSciences Corp.
  • Integra LifeSciences Corp. - Overview
  • Integra LifeSciences Corp. - Business segments
  • Integra LifeSciences Corp. - Key offerings
  • Integra LifeSciences Corp. - Segment focus
  • SWOT
• 15.11 Inventia Life Science
  • Inventia Life Science - Overview
  • Inventia Life Science - Product / Service
  • Inventia Life Science - Key offerings
  • SWOT
• 15.12 Japan Tissue Engineering Co.
  • Japan Tissue Engineering Co. - Overview
  • Japan Tissue Engineering Co. - Product / Service
  • Japan Tissue Engineering Co. - Key offerings
  • SWOT
• 15.13 MiMedx Group Inc.
  • MiMedx Group Inc. - Overview
  • MiMedx Group Inc. - Business segments
  • MiMedx Group Inc. - Key offerings
  • MiMedx Group Inc. - Segment focus
  • SWOT
• 15.14 Organogenesis Holdings Inc.
  • Organogenesis Holdings Inc. - Overview
  • Organogenesis Holdings Inc. - Business segments
  • Organogenesis Holdings Inc. - Key offerings
  • Organogenesis Holdings Inc. - Segment focus
  • SWOT
• 15.15 REPROCELL Inc.
  • REPROCELL Inc. - Overview
  • REPROCELL Inc. - Product / Service
  • REPROCELL Inc. - Key offerings
  • SWOT
• 15.16 Secant Group
  • Secant Group - Overview
  • Secant Group - Product / Service
  • Secant Group - Key offerings
  • SWOT
• 15.17 Synthasome Inc.
  • Synthasome Inc. - Overview
  • Synthasome Inc. - Product / Service
  • Synthasome Inc. - Key offerings
  • SWOT
• 15.18 Tissue Regenix Group Plc
  • Tissue Regenix Group Plc - Overview
  • Tissue Regenix Group Plc - Business segments
  • Tissue Regenix Group Plc - Key offerings
  • Tissue Regenix Group Plc - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations